Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04411849 · ClinicalTrials.gov registry record · NA
Multilevel HPV Self-Testing Intervention for the Increase of Cervical Cancer Screening Among Women in Appalachia
A NA study, sponsored by Ohio State University Comprehensive Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 802
- Enrollment target
NCT04411849 is a NA study that has completed, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 802 participants.
The verdict
NCT04411849, a NA study, has completed, sponsored by Ohio State University Comprehensive Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 802 participants
- Enrollment target
Study Summary
This trial studies how well a multilevel human papillomavirus (HPV) self-testing intervention works in increasing cervical cancer screening among women in Appalachia. Most cases of cervical cancer occur among unscreened and underscreened women. A multilevel HPV self-testing intervention may help to improve cervical cancer screening rates.
Interventions
- OTHER Best Practice
- OTHER Informational Intervention
- BEHAVIORAL Patient Navigation Program
- PROCEDURE HPV Self-Collection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 802 participants |
| Start Date | 2021-08-27 |
| Est. Completion | 2024-06-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04411849
The ClinicalTrials.gov registry entry for NCT04411849 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 802 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University Comprehensive Cancer Center, which has 341 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Best Practice is the first listed.
NCT04411849 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04411849 about?
NCT04411849 is a clinical study titled "Multilevel HPV Self-Testing Intervention for the Increase of Cervical Cancer Screening Among Women in Appalachia". This trial studies how well a multilevel human papillomavirus (HPV) self-testing intervention works in increasing cervical cancer screening among women in Appalachia. Most cases of cervical cancer occur among unscreened and underscreened women. A multilevel HPV self-testing intervention may help to ...
What is the current status of trial NCT04411849?
This trial is currently completed. It is a NA study. The enrollment target is 802 participants. The study started on 2021-08-27. Estimated completion is 2024-06-11.
What interventions are being tested in trial NCT04411849?
The interventions under investigation include: Best Practice (OTHER), Informational Intervention (OTHER), Patient Navigation Program (BEHAVIORAL), HPV Self-Collection (PROCEDURE).
Who is sponsoring clinical trial NCT04411849?
This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.